top of page

Hematology & Immunology

Hematopoietic stem cell hierarchy

Core Principle of Hematopoietic Stem Cell Hierarchy
🧷 Hematopoiesis is the highly regulated process of blood cell formation from a single pluripotent hematopoietic stem cell (HSC) through progressive lineage restriction.
🧷 The hierarchy follows a branching pattern: HSC → multipotent progenitors → lineage-committed progenitors → precursors → mature blood cells.
🧷 Each differentiation step involves loss of self-renewal capacity and gain of lineage-specific markers, driven by transcription factors and cytokine signals.
🧷 Board pearl: HSCs are defined by two key properties — self-renewal (ability to divide and maintain the stem cell pool) and multipotency (ability to differentiate into all blood cell lineages).
Solid White Background
The Hematopoietic Stem Cell: Foundation of the Hierarchy
📍 HSCs reside primarily in the bone marrow niche, where they remain largely quiescent (G₀ phase) to preserve their self-renewal capacity.
📍 Surface markers: CD34⁺ CD38⁻ (human) or Lin⁻ Sca-1⁺ c-Kit⁺ (mouse). CD34 is the classic HSC marker tested on boards.
📍 HSCs comprise only 0.05% of bone marrow cells but can reconstitute the entire hematopoietic system after transplantation.
📍 Two types: long-term HSCs (LT-HSCs) maintain lifelong hematopoiesis; short-term HSCs (ST-HSCs) provide transient reconstitution.
📍 Board pearl: The gold standard test for HSC function is the ability to reconstitute lethally irradiated recipients — this defines true stem cell activity.
Solid White Background
First Branch Point: Myeloid vs Lymphoid Commitment
🔹 HSCs first differentiate into multipotent progenitors (MPPs) that have lost self-renewal but retain multilineage potential.
🔹 MPPs then commit to either common myeloid progenitor (CMP) or common lymphoid progenitor (CLP) — the fundamental branch point of hematopoiesis.
🔹 CMP gives rise to all myeloid cells: erythrocytes, megakaryocytes, granulocytes (neutrophils, eosinophils, basophils), and monocytes.
🔹 CLP gives rise to all lymphoid cells: B cells, T cells, NK cells, and dendritic cells.
🔹 This commitment is driven by master transcription factors: PU.1 and C/EBPα promote myeloid fate; Notch1 and Ikaros promote lymphoid fate.
Solid White Background
Common Myeloid Progenitor Differentiation
⭐ CMP further branches into two lineage-restricted progenitors:
⭐ Megakaryocyte-erythroid progenitor (MEP) → produces red blood cells and platelets
⭐ Granulocyte-monocyte progenitor (GMP) → produces neutrophils, eosinophils, basophils, and monocytes
⭐ MEP commitment requires GATA-1 and FOG-1 transcription factors; GMP commitment requires PU.1 and C/EBPα
⭐ Board pearl: Mutations in GATA-1 cause congenital dyserythropoietic anemia and thrombocytopenia, highlighting its role in the MEP lineage.
Solid White Background
Erythroid Differentiation Pathway
✅ MEP → burst-forming unit-erythroid (BFU-E) → colony-forming unit-erythroid (CFU-E) → proerythroblast → basophilic erythroblast → polychromatophilic erythroblast → orthochromic erythroblast → reticulocyte → mature RBC
✅ Key features: progressive hemoglobin synthesis, nuclear condensation, and eventual enucleation
✅ Erythropoietin (EPO) acts primarily on CFU-E stage, promoting survival and proliferation
✅ GATA-1 and KLF1 are master regulators; mutations cause various congenital anemias
✅ Board pearl: The reticulocyte count reflects erythropoietic activity — elevated in hemolysis or blood loss, decreased in aplastic anemia.
Solid White Background
Megakaryocyte Differentiation and Platelet Production
🧠 MEP → megakaryocyte progenitor → promegakaryoblast → megakaryoblast → megakaryocyte → platelets
🧠 Unique feature: endomitosis (DNA replication without cell division) creates polyploid cells up to 128N
🧠 Thrombopoietin (TPO) is the primary regulator, binding c-Mpl receptor throughout differentiation
🧠 Mature megakaryocytes extend proplatelets through marrow sinusoids, releasing 2000-3000 platelets per cell
🧠 Board pearl: Essential thrombocythemia involves JAK2, CALR, or MPL mutations affecting the TPO signaling pathway.
Solid White Background
Granulocyte Differentiation: Neutrophil Pathway
⚡ GMP → myeloblast → promyelocyte → myelocyte → metamyelocyte → band → segmented neutrophil
⚡ Promyelocyte stage contains primary (azurophilic) granules with myeloperoxidase
⚡ Myelocyte stage develops secondary (specific) granules containing lactoferrin and neutrophil-specific proteins
⚡ G-CSF drives neutrophil production and release from marrow; stress causes "left shift" with increased bands
⚡ Board pearl: Acute promyelocytic leukemia (APL) arrests at promyelocyte stage due to PML-RARA fusion, causing bleeding from DIC.
Solid White Background
Eosinophil and Basophil Differentiation
📌 Both arise from GMP through distinct transcriptional programs
📌 Eosinophils: IL-5 is the primary driver; GATA-1 and C/EBP transcription factors required; contain major basic protein and eosinophil peroxidase
📌 Basophils: IL-3 drives differentiation; contain histamine and heparin; least common granulocyte (<1% of WBCs)
📌 Eosinophilia suggests parasitic infection, allergy, drug reaction, or malignancy (especially Hodgkin lymphoma)
📌 Board pearl: Hypereosinophilic syndrome requires >1500 eosinophils/μL for >6 months with organ damage — can involve FIP1L1-PDGFRA fusion responsive to imatinib.
Solid White Background
Monocyte-Macrophage-Dendritic Cell Axis
📣 GMP → monoblast → promonocyte → monocyte → tissue macrophage or dendritic cell
📣 M-CSF (CSF1) drives monocyte production; monocytes circulate 1-3 days before entering tissues
📣 Tissue signals determine final differentiation: microglia (brain), Kupffer cells (liver), alveolar macrophages (lung), osteoclasts (bone)
📣 Dendritic cells can arise from both myeloid (mDC) and lymphoid (pDC) pathways
📣 Board pearl: Langerhans cell histiocytosis shows CD1a⁺ Langerin⁺ cells with "tennis racket" Birbeck granules on EM.
Solid White Background
Common Lymphoid Progenitor Differentiation
🔸 CLP gives rise to all adaptive immune cells through distinct niches and signals
🔸 B cell pathway: CLP → pro-B → pre-B → immature B → mature B cell (bone marrow development)
🔸 T cell pathway: CLP → thymic progenitor → double negative → double positive → single positive T cell (thymic development)
🔸 NK cell pathway: CLP → NK progenitor → immature NK → mature NK cell (bone marrow and secondary lymphoid organs)
🔸 IL-7 is essential for both B and T cell development; IL-15 drives NK cell development
🔸 Board pearl: X-linked SCID results from IL-2Rγ mutations, affecting T and NK cells but sparing B cells (T⁻B⁺NK⁻ phenotype).
Solid White Background
B Cell Development in Bone Marrow
🧷 Pro-B cell: DJ rearrangement of heavy chain; expresses CD19, CD10, TdT
🧷 Pre-B cell: VDJ rearrangement complete; μ heavy chain pairs with surrogate light chain to form pre-BCR
🧷 Immature B cell: light chain rearrangement; expresses surface IgM; undergoes negative selection
🧷 Key transcription factors: E2A, EBF1, and PAX5 drive B cell commitment
🧷 Board pearl: Acute lymphoblastic leukemia (ALL) markers reflect arrested development — TdT⁺ indicates lymphoblast; CD10⁺ suggests B-ALL.
Solid White Background
T Cell Development in Thymus
📍 Double negative (DN) stages: DN1-DN4, characterized by CD44/CD25 expression and TCR β-chain rearrangement
📍 Double positive (DP): CD4⁺CD8⁺, undergoes positive and negative selection based on MHC interaction
📍 Single positive (SP): CD4⁺ or CD8⁺, ready for peripheral circulation
📍 Notch signaling is essential for T cell commitment; GATA-3 drives CD4⁺ fate; Runx3 drives CD8⁺ fate
📍 Board pearl: DiGeorge syndrome (22q11.2 deletion) causes thymic hypoplasia → absent T cells but normal B cells → recurrent viral/fungal infections.
Solid White Background
Cytokine Control of Hematopoiesis
🔹 Stem cell factor (SCF/c-Kit ligand): maintains HSCs and early progenitors
🔹 Flt3 ligand: expands early lymphoid and myeloid progenitors
🔹 IL-3: multilineage growth factor supporting various progenitors
🔹 Lineage-specific cytokines: EPO (erythroid), TPO (megakaryocyte), G-CSF (neutrophil), M-CSF (monocyte), IL-5 (eosinophil)
🔹 Board pearl: Polycythemia vera shows EPO-independent erythrocytosis due to JAK2 V617F mutation causing constitutive activation.
Solid White Background
Transcription Factor Networks in Hematopoiesis
⭐ Master regulators determine lineage fate through cross-antagonism
⭐ GATA-1 vs PU.1: the paradigm of lineage decision — GATA-1 promotes erythroid/megakaryocyte; PU.1 promotes myeloid/lymphoid
⭐ C/EBPα drives granulocyte differentiation; mutations cause specific AML subtypes
⭐ RUNX1 (AML1) is essential for definitive hematopoiesis; t(8;21) RUNX1-ETO fusion causes AML
⭐ Board pearl: Core binding factor AMLs [t(8;21) and inv(16)] have relatively good prognosis despite being AML.
Solid White Background
Hematopoietic Stem Cell Niche
✅ HSCs reside in specialized bone marrow microenvironments that regulate quiescence and self-renewal
✅ Endosteal niche: near bone surface, maintains HSC quiescence through low oxygen and specific signals
✅ Vascular niche: near sinusoids, supports HSC proliferation and differentiation
✅ Key niche cells: osteoblasts, mesenchymal stromal cells, endothelial cells, sympathetic neurons
✅ CXCL12-CXCR4 axis anchors HSCs; AMD3100 blocks this interaction for stem cell mobilization
✅ Board pearl: G-CSF mobilizes HSCs by disrupting CXCL12-CXCR4 binding, allowing harvest for transplantation.
Solid White Background
Clinical Markers of Hematopoietic Stages
🧠 CD34: HSCs and early progenitors; used for stem cell enumeration
🧠 CD117 (c-Kit): HSCs and early progenitors; also on mast cells and germ cells
🧠 CD33: myeloid lineage from myeloblast onward; target for AML therapy (gemtuzumab)
🧠 CD15: mature myeloid cells; positive in Hodgkin lymphoma Reed-Sternberg cells
🧠 TdT: lymphoblasts only; distinguishes ALL from mature lymphomas
🧠 Board pearl: Flow cytometry immunophenotyping is essential for leukemia classification — know CD34/CD117 (blasts), CD13/CD33 (myeloid), CD19/CD20 (B cell), CD3/CD5 (T cell).
Solid White Background
Disorders of Hematopoietic Hierarchy
⚡ Aplastic anemia: HSC failure → pancytopenia with empty marrow
⚡ Myelodysplastic syndromes: ineffective hematopoiesis with dysplastic changes
⚡ Leukemias: arrested differentiation at specific stages (AML at myeloblast, ALL at lymphoblast)
⚡ Myeloproliferative neoplasms: increased production of one or more mature lineages
⚡ Board pearl: The level of differentiation arrest determines leukemia phenotype — earlier arrest (blast) is acute; later arrest allows maturation (chronic).
Solid White Background
Hematopoietic Growth Factor Therapeutics
📌 Erythropoiesis-stimulating agents (ESAs): recombinant EPO for anemia of chronic kidney disease
📌 G-CSF (filgrastim): reduces neutropenia duration after chemotherapy
📌 GM-CSF (sargramostim): broader myeloid stimulation, used less frequently
📌 Thrombopoietin receptor agonists (romiplostim, eltrombopag): for immune thrombocytopenia
📌 IL-11 (oprelvekin): thrombocytopenia treatment (limited use due to side effects)
📌 Board pearl: ESAs increase thrombosis risk and are contraindicated in cancer patients not receiving chemotherapy due to tumor progression concerns.
Solid White Background
Board Question Stem Patterns
📣 Pancytopenia with hypocellular marrow and no blasts → aplastic anemia affecting HSCs
📣 Auer rods in myeloblasts → acute myeloid leukemia with arrested granulocyte development
📣 Philadelphia chromosome with maturation to neutrophils → chronic myeloid leukemia
📣 TdT⁺ CD19⁺ CD10⁺ blasts → B-cell acute lymphoblastic leukemia
📣 Teardrop cells and dry tap → myelofibrosis disrupting marrow architecture
📣 Hypersegmented neutrophils → megaloblastic anemia affecting DNA synthesis
📣 CD34⁺ cell collection for transplant → hematopoietic stem cell harvest
Solid White Background
One-Line Recap
🔸 Hematopoiesis follows a strict hierarchy from self-renewing CD34⁺ HSCs through multipotent progenitors that branch at the CMP/CLP decision point into all blood lineages, regulated by cytokine-transcription factor networks (EPO-GATA1 for erythroid, G-CSF-C/EBPα for granulocyte, IL-7-PAX5 for B cells), with differentiation arrests causing leukemias and regulatory failures causing cytopenias or myeloproliferative disorders.
Solid White Background
bottom of page